Alvotech

XNAS:ALVO 4:00:00 PM EDT

3.65

-0.27 (-6.89%)

7:52:18 PM EDT: $3.63 -0.02 (-0.55%)

Market Cap (Intraday)	1.14B
Current PE	N/A
Forward PE	60.83
2yr Forward PE	18.25

See more stats

Estimates Current Quarter

Revenue	$135.5 Million
Adjusted EPS	-$0.02

See more estimates

10-Day MA	$3.44
50-Day MA	$3.46
200-Day MA	$5.52

See more pivots

Alvotech Stock, XNAS:ALVO

9, rue de Bitbourg, 28th floor, Luxembourg, Luxembourg 1273

Luxembourg

Phone: +352.422.4500

Number of Employees: 1026

http://www.alvotech.com

Description

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by RÃ?Â³bert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.